|
1
|
de Witte T, Bowen D, Robin M, Malcovati L,
Niederwieser D, Yakoub-Agha I, Mufti GJ, Fenaux P, Sanz G, Martino
R, et al: Allogeneic hematopoietic stem cell transplantation for
MDS and CMML: Recommendations from an international expert panel.
Blood. 129:1753–1762. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pellagatti A and Boultwood J: The
molecular pathogenesis of the myelodysplastic syndromes. Eur J
Haematol. 95:3–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mandal N: Bibliometric analysis of global
publication output and collaboration structure study in microRNA
research. Scientometrics. 98:2011–2037. 2014. View Article : Google Scholar
|
|
4
|
Kuang X, Chi J and Wang L: Deregulated
microRNA expression and its pathogenetic implications for
myelodysplastic syndromes. Hematology. 21:593–602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simmer F, Venderbosch S, Dijkstra JR,
Vink-Börger EM, Faber C, Mekenkamp LJ, Koopman M, De Haan AF, Punt
CJ and Nagtegaal ID: MicroRNA-143 is a putative predictive factor
for the response to fluoropyrimidine-based chemotherapy in patients
with metastatic colorectal cancer. Oncotarget. 6:22996–23007. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu Y, Ma Z, He Y, Liu W, Su Y and Tang Z:
PART-1 functions as a competitive endogenous RNA for promoting
tumor progression by sponging miR-143 in colorectal cancer. Biochem
Biophys Res Commun. 490:317–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu B, Liu X and Chang H: MicroRNA-143
inhibits colorectal cancer cell proliferation by targeting MMP7.
Minerva Med. 108:13–19. 2017.
|
|
8
|
Zhou P, Chen WG and Li XW: MicroRNA-143
acts as a tumor suppressor by targeting hexokinase 2 in human
prostate cancer. Am J Cancer Res. 5:2056–2063. 2015.PubMed/NCBI
|
|
9
|
Rodríguez M, Bajo-Santos C, Hessvik NP,
Lorenz S, Fromm B, Berge V, Sandvig K, Linē A and Llorente A:
Identification of non-invasive miRNAs biomarkers for prostate
cancer by deep sequencing analysis of urinary exosomes. Mol Cancer.
16:1562017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang F, Liu J, Zou Y, Jiao Y, Huang Y, Fan
L, Li X, Yu H, He C, Wei W, et al: MicroRNA-143-3p, up-regulated in
H. pylori-positive gastric cancer, suppresses tumor growth,
migration and invasion by directly targeting AKT2. Oncotarget.
8:28711–28724. 2017.PubMed/NCBI
|
|
11
|
Du F, Feng Y, Fang J and Yang M:
MicroRNA-143 enhances chemosensitivity of Quercetin through
autophagy inhibition via target GABARAPL1 in gastric cancer cells.
Biomed Pharmacother. 74:169–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Wang X and Zhang Y and Zhang Y: E3
ubiquitin ligase isolated by differential display regulates
cervical cancer growth in vitro and in vivo via microRNA-143. Exp
Ther Med. 12:676–682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong P, Xiong Y, Hanley SJB, Yue J and
Watari H: Musashi-2, a novel oncoprotein promoting cervical cancer
cell growth and invasion, is negatively regulated by p53-induced
miR-143 and miR-107 activation. J Exp Clin Cancer Res. 36:1502017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen JH, Yang R, Zhang W and Wang YP:
Functions of microRNA-143 in the apoptosis, invasion and migration
of naso-pharyngeal carcinoma. Exp Ther Med. 12:3749–3755. 2016.
View Article : Google Scholar
|
|
15
|
He B, Xu Z, Chen J, Zheng D, Li A and
Zhang LS: Upregulated microRNA-143 inhibits cell proliferation in
human nasopha-ryngeal carcinoma. Oncol Lett. 12:5023–5028. 2016.
View Article : Google Scholar
|
|
16
|
Li WH, Wu HJ, Li YX, Pan HG, Meng T and
Wang X: MicroRNA-143 promotes apoptosis of osteosarcoma cells by
caspase-3 activation via targeting Bcl-2. Biomed Pharmacother.
80:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Wang G, Ding C, Liu P, Wang R,
Ding W, Tong D, Wu D, Li C, Wei Q, et al: Increased circular RNA
UBAP2 acts as a sponge of miR-143 to promote osteosarcoma
progression. Oncotarget. 8:61687–61697. 2017.PubMed/NCBI
|
|
18
|
Akao Y, Nakagawa Y, Iio A and Naoe T: Role
of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia
Jurkat cells. Leuk Res. 33:1530–1538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ozdogan H, Gur Dedeoglu B, Oztemur
Islakoglu Y, Aydos A, Kose S, Atalay A, Yegin ZA, Avcu F, Uckan
Cetinkaya D and Ilhan O: DICER1 gene and miRNA dysregulation in
mesen-chymal stem cells of patients with myelodysplastic syndrome
and acute myeloblastic leukemia. Leuk Res. 63:62–71. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Votavova H, Grmanova M, Dostalova
Merkerova M, Belickova M, Vasikova A, Neuwirtova R and Cermak J:
Differential expression of microRNAs in CD34+ cells of
5q- syndrome. J Hematol Oncol. 4:12011. View Article : Google Scholar
|
|
21
|
Dostalova Merkerova M, Krejcik Z, Votavova
H, Belickova M, Vasikova A and Cermak J: Distinctive microRNA
expression profiles in CD34+ bone marrow cells from
patients with myelo-dysplastic syndrome. Eur J Hum Genet.
19:313–319. 2011. View Article : Google Scholar
|
|
22
|
Wang L, Luo J, Nian Q, Xiao Q, Yang Z and
Liu L: Ribosomal protein S14 silencing inhibits growth of acute
myeloid leukemia transformed from myelodysplastic syndromes via
activating p53. Hematology. 19:225–231. 2014. View Article : Google Scholar
|
|
23
|
Liu Z, Ding K, Li L, Liu H, Wang Y, Liu C
and Fu R: A novel histone deacetylase inhibitor Chidamide induces
G0/G1 arrest and apoptosis in myelodysplastic syndromes. Biomed
Pharmacother. 83:1032–1037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Tiscornia G, Singer O and Verma IM:
Production and purification of lentiviral vectors. Nat Protoc.
1:241–245. 2006. View Article : Google Scholar
|
|
26
|
Proetzel G and Wiles MV: Mouse Models for
Drug Discovery: Methods and Protocols. Humana Press; Totowa, NJ:
pp. 2010
|
|
27
|
Wu L, Li X, Su J, He Q, Zhang X, Chang C
and Pu Q: Efficacy and safety of CHG regimen (low-dose cytarabine,
homoharringtonine with G-CSF priming) as induction chemotherapy for
elderly patients with high-risk MDS or AML transformed from MDS. J
Cancer Res Clin Oncol. 137:1563–1569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pramanik D, Campbell NR, Karikari C,
Chivukula R, Kent OA, Mendell JT and Maitra A: Restitution of tumor
suppressor microRNAs using a systemic nanovector inhibits
pancreatic cancer growth in mice. Mol Cancer Ther. 10:1470–1480.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guerenne L, Beurlet S, Said M, Gorombei P,
Le Pogam C, Guidez F, de la Grange P, Omidvar N, Vanneaux V, Mills
K, et al: GEP analysis validates high risk MDS and acute myeloid
leukemia post MDS mice models and highlights novel dysregulated
pathways. J Hematol Oncol. 9:52016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
eLife. 4:42015. View Article : Google Scholar
|
|
31
|
Zhou J, Chaudhry H, Zhong Y, Ali MM,
Perkins LA, Owens WB, Morales JE, McGuire FR, Zumbrun EE, Zhang J,
et al: Dysregulation in microRNA expression in peripheral blood
mononuclear cells of sepsis patients is associated with
immunopathology. Cytokine. 71:89–100. 2015. View Article : Google Scholar
|
|
32
|
Shen JZ, Zhang YY, Fu HY, Wu DS and Zhou
HR: Overexpression of microRNA-143 inhibits growth and induces
apoptosis in human leukemia cells. Oncol Rep. 31:2035–2042. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Clark J, Wunderlich M, Fan C,
Davis A, Chen S, Guan JL, Mulloy JC, Kumar A and Zheng Y: Autophagy
is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and
anti-leukemic effect of chloroquine. Autophagy. 13:955–966. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang T, Luo Y, Wang T and Yang JY:
MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell
proliferation, migration and invasion in vitro and tumor growth in
nude mice. Leuk Lymphoma. 53:2033–2040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vogel T and Gruss P: Expression of
leukaemia associated transcription factor Af9/Mllt3 in the cerebral
cortex of the mouse. Gene Expr Patterns. 9:83–93. 2009. View Article : Google Scholar
|
